JB
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Prevalence and factors associated with severe fatigue 2 years into the COVID-19 pandemic : a cross-sectional population-based study in Geneva, Switzerland | BMJ open | 2025 | 29 | 11 | |||
Covid-19 pandemic-related changes in teleworking, emotional exhaustion, and occupational burnout : a cross-sectional analysis of a cohort study | BMC public health | 2025 | 10 | 4 | |||
Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based study | The Lancet regional health. Europe | 2023 | 106 | 82 | |||
Long term anti-SARS-CoV-2 antibody kinetics and correlate of protection against Omicron BA.1/BA.2 infection | Nature communications | 2023 | 121 | 31 | |||
Occupational risk of SARS-CoV-2 infection and reinfection during the second pandemic surge: a cohort study | Occupational and environmental medicine | 2022 | 211 | 58 | |||
Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, Switzerland | BMJ open | 2022 | 187 | 67 | |||
Determinants of adolescents' Health-Related Quality of Life and psychological distress during the COVID-19 pandemic | PloS one | 2022 | 136 | 87 | |||
Identification du patient complexe pour une prise en charge interprofessionnelle | Revue médicale suisse | 2022 | 230 | 368 | |||
COVID-19-related school disruptions and well-being of children and adolescents in Geneva | Journal of paediatrics and child health | 2022 | 83 | 62 | |||
Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021 | Euro surveillance | 2021 | 210 | 100 | |||
Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland | Nature Communications | 2021 | 226 | 109 | |||
Association between SARS-CoV-2 Seroprevalence in Nursing Home Staff and Resident COVID-19 Cases and Mortality: A Cross-Sectional Study | Viruses | 2021 | 218 | 78 | |||
Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak | The Lancet Infectious Diseases | 2021 | 241 | 159 | |||
Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance | Clinical Microbiology and Infection | 2021 | 250 | 208 | |||
Itinéraire clinique pour l'insuffisance cardiaque : un programme conçu par des médecins de premier recours genevois | Revue médicale suisse | 2012 | 605 | 1 |